CellEDIT - CRISPR-Edited MDA MB 231 Cell Line

We provide you with a custom and high-quality engineered MDA MB 231 cell line to support your research.

Concentrate on your experiments and let us handle your CRISPR-engineered MDA MB 231 cell line.

We’ll take care of the CRISPR editing so you can speed up your experiment and complete your project earlier. 

The MDA MB 231 cell line is derived from a human breast adenocarcinoma. With their nature and hormone responsiveness, MDA MB 231 cells are widely used in biological research and industrial applications.

MDA MB 231 Cell Line Information



Tissue Type

Breast - Mammary Gland

Cell Type




Donor Information







MDA MB 231 Cell Line Applications

  Tumor Biology: MDA MB 231 cells are used as a model for studying triple negative breast cancers (TNBC) a very aggressive subtype of this disease.


 Drug Resistance: Investigating the development of resistance to chemotherapy and other treatments.


 Screening Anti-Cancer Drugs: Evaluating the efficacy of new anti-cancer compounds and therapeutic agents.


 Mechanistic Studies: Unraveling the molecular and cellular mechanisms of drug actions in triple negative breast cancers.


 Drug Discovery: Using MDA MB cell lines in automated platforms for high throughput screening of large compound libraries.


Related Case Studies

Elevate your research with our expertise. MDA MB 231 cell lines contribute significantly to our understanding of breast cancer and the development of new therapeutic strategies. With the CellEDIT workflow, we can design custom CRISPR-edited MDA MB 231 cell lines through direct intra-nuclear injection, suited for your project needs.

CellEDIT Engineered MDA MB 231 Cell Line - Cytosurge
Efficient on 
Hard-to-transfect cells
CellEDIT Engineered MDA MB 231 Cell Line - Cytosurge
direct intra-nuclear delivery
CellEDIT Engineered MDA MB 231 Cell Line - Cytosurge
Minimized Off-Target

Immortalized Cells

Discover how the CellEDIT workflow was used to generate 5 monoclonal Hprt knockouts in C2C12 cell line through direct intra-nuclear injection of only 51 cells. 


Hard-to-Transfect Cells

Explore how the CellEDIT workflow was used to produce 
3 monoclonal HPRT1 knockouts in SK-MES-1 cell, a notoriously hard-to-transfect cell line.


Multiplex Gene Editing

Find out how the CellEDIT workflow boosted the editing efficiency while preserving cell characteristics and functionality in single and multiple KO CHO-K1 clones.

 Available Edits using CellEDIT Engineered Cells


Save time in the lab by powering your research with CellEDIT. Confidently streamline your drug discovery workflow and investigate gene function with effective CRISPR knockouts.

 Find out more


Leverage CellEDIT's expertise to increase your research output. Confidently generate disease models to fasten your discoveries. Access Knock-ins CRISPR Cell Lines without sacrificing time.

 Find out more

Schedule A Meeting Now to Use CRISPR-Edited MDA MB 231 Cell Lines

 Related Resources

Browse All Engineered Cell Lines